Membranous nephropathy associated with fluconazole treatment.
About 6% to 9% of cases of membranous nephropathy develop secondary to exposure to drugs. Fluconazole is a widely used antifungal agent that was never implicated in the development of membranous nephropathy. We report the case of a patient found to have membranous nephropathy secondary to fluconazole treatment. This patient had recurrent episodes of nephrotic syndrome caused by readministration of fluconazole. This is the first reported case of membranous nephropathy caused by fluconazole treatment and the first case report of the clinical course of recurrent membranous nephropathy caused by reexposure to this medication.
Shin
Gyu-Tae
GT
Department of Nephrology, Ajou University School of Medicine, Suwon, Korea. gtshin@ajou.ac.kr
Yim
Hyunee
H
Park
Jieun
J
Kim
Heungsoo
H
D005260:Female; D015725:Fluconazole / Q000009:adverse effects*; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008875:Middle Aged
D015725:Fluconazole